Cite
Singhal D, Hahn CN, Feurstein S, et al. Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer. Leukemia. 2021;35(11):3245-3256doi: 10.1038/s41375-021-01246-w.
Singhal, D., Hahn, C. N., Feurstein, S., Wee, L. Y. A., Moma, L., Kutyna, M. M., Chhetri, R., Eshraghi, L., Schreiber, A. W., Feng, J., Wang, P. P., Babic, M., Parker, W. T., Gao, S., Moore, S., Das, S., Thomas, D., Pattnaik, S., Brown, A. L., D'Andrea, R. J., Poplawski, N. K., Thomas, D., Scott, H. S., Godley, L. A., & Hiwase, D. K. (2021). Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer. Leukemia, 35(11), 3245-3256. https://doi.org/10.1038/s41375-021-01246-w
Singhal, Deepak, et al. "Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer." Leukemia vol. 35,11 (2021): 3245-3256. doi: https://doi.org/10.1038/s41375-021-01246-w
Singhal D, Hahn CN, Feurstein S, Wee LYA, Moma L, Kutyna MM, Chhetri R, Eshraghi L, Schreiber AW, Feng J, Wang PP, Babic M, Parker WT, Gao S, Moore S, Das S, Thomas D, Pattnaik S, Brown AL, D'Andrea RJ, Poplawski NK, Thomas D, Scott HS, Godley LA, Hiwase DK. Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer. Leukemia. 2021 Nov;35(11):3245-3256. doi: 10.1038/s41375-021-01246-w. Epub 2021 Apr 13. PMID: 33850299.
Copy
Download .nbib